Page 179 - Orange Book Cumulative Supplement 10 October 2012
P. 179
A - 42
PATENT & EXCLUSIVITY DRUG PRODUCT LIST - CUMULATIVE SUPPLEMENT 10 - October 2012
See List footnote for information regarding List content
PATENT PATENT EXCLUSIVITY
EXPIRATION PATENT DELIST EXCLUSIVITY EXPIRATION
APPL/PROD DATE REQUESTED DATE
NO PATENT NO CODES CODE(S)
RITONAVIR - NORVIR
N022417 001 8268349 Aug 25, 2024 DP
8268349*PED Feb 25, 2925
RIVASTIGMINE - EXELON
N022083 005 5602176 Feb 11, 2014 DS DP U-322 NS
Aug 31, 2015
6316023 Jan 08, 2019 DP
6335031 Jan 08, 2019 DP
RIZATRIPTAN BENZOATE - MAXALT
N020864 001 5602162 Jan 28, 2012 Y
5602162*PED Jul 28, 2012
RIZATRIPTAN BENZOATE - MAXALT
N020864 002 5602162 Jan 28, 2012 Y
5602162*PED Jul 28, 2012
RIZATRIPTAN BENZOATE - MAXALT-MLT
N020865 001 5602162 Jan 28, 2012 U-240 Y
5602162*PED Jul 28, 2012
RIZATRIPTAN BENZOATE - MAXALT-MLT
N020865 002 5602162 Jan 28, 2012 U-240 Y
5602162*PED Jul 28, 2012
ROMIDEPSIN - ISTODAX
N022393 001 4977138 Aug 22, 2013 DS DP
ROTIGOTINE - NEUPRO
N021829 001 8246979 Sep 01, 2027 DP U-1273 I-647 Apr 02, 2015
8246979 Sep 01, 2027 DP U-1272 I-646 Apr 02, 2015
8246980 Nov 27, 2025 DP
ROTIGOTINE - NEUPRO
N021829 002 8246979 Sep 01, 2027 DP U-1273 I-647 Apr 02, 2015
8246979 Sep 01, 2027 DP U-1272 I-646 Apr 02, 2015
8246980 Nov 27, 2025 DP
ROTIGOTINE - NEUPRO
N021829 003 8246979 Sep 01, 2027 DP U-1273 I-647 Apr 02, 2015
8246979 Sep 01, 2027 DP U-1272 I-646 Apr 02, 2015
8246980 Nov 27, 2025 DP
ROTIGOTINE - NEUPRO
N021829 004 6699498 Nov 27, 2020 DP I-647 Apr 02, 2015
6884434 Mar 30, 2021 DP I-646 Apr 02, 2015
7413747 Mar 18, 2019 DP
8246979 Sep 01, 2027 DP U-1273
8246979 Sep 01, 2027 DP U-1272
8246980 Nov 27, 2025 DP
